Search results
3 days ago · View the fully annotated map and sequence of your vector. Download the vector report in various formats including PDF, GenBank, FASTA and SnapGene. View the price and turnaround of your vector or submit a price inquiry. Add the vector to your shopping cart along with downstream services such as virus packaging.
4 days ago · Qualifying programs can receive up to $300,000 in G-Rex® devices, ... the program aims to expedite clinical data generation, reduce the complexity of the development process, increase the ...
3 days ago · Huge inventory of vector backbones and vector components saving you time and money on cloning (only ~20% of our projects need de novo gene synthesis). Functionally validated vector backbones and components providing reliable experimental results. Utilization of versatile cloning technologies for generating vectors with simple to complex designs.
- Vectorbuilder
- $149 - $329
- 4
5 days ago · The G-Rex® Grant Program will provide academic and commercial institutions engaged in IND enabling pre-clinical research, process development, and/or ongoing GMP manufacturing of cell and gene therapies with the material resources and services needed to implement or optimize a highly efficient G-Rex® based cell manufacturing platform.
May 16, 2024 · Yet with the next generation of gene editing tools also on the horizon, many patients could benefit in the long run from this nascent field. Metagenomi, a biotech based in Emeryville, California ...
May 23, 2024 · Trendline. Gene Therapy. Rapid scientific advances have put the gene therapy field at the forefront of biomedical research. But, as recent setbacks have shown, researchers and drugmakers still face major challenges. By BioPharma Dive staff. Merck KGaA to buy gene therapy tools maker for $600M.
People also ask
Which first generation gene editing companies are getting started?
What services do we offer besides molecular cloning of DNA vectors?
Can new gene editing nucleases solve the cost of gene editing therapies?
May 6, 2024 · The one huge obstacle standing in the way of progress on gene-editing medicine. The genetic data that underpins CRISPR has a big diversity problem. by Charlotte Hu. May 6, 2024, 6:14 AM PDT. There ...
